Drugmakers reach settlement to avoid a trial - report - Breaking The News
Download our appPlay StoreApp Store

Drugmakers reach settlement to avoid a trial - report

EPA-EFE/JIM HOLLANDER

Four pharmaceutical companies, McKesson Corp., Teva Pharmaceutical Industries Ltd., AmerisourceBergen Corp. and Cardinal Health Inc. reached a settlement on Monday in order to avoid a trial.

According to persons familiar with the situation, the details of the settlement should be released later in the day. Wall Street Journal reported that all four companies were held responsible for the opioid crisis. Fifth defendant Walgreens Boots Alliance wasn't included in this deal and it's still not known if the trial will proceed with only one appellant.

The so-called Ohio trial is very closely monitored as there were plenty of other pharmaceutical companies that were sued for pushing opioid painkillers for wider usage without warning of the risk of addiction.

Related Stocks
Walgreens Boots A...
Cardinal Health
Cencora
Teva Pharmaceutical
McKesson
Related News
Sycamore to take Walgreens private in up to $24B deal
Walgreens Boots Alliance has reached a deal worth up to $23.7 billion with private equity group Sycamore Partners that will bring the pharmacy chain's nearly 100-year run as a publicly traded company to an end.Sycamore will pay $11.45 per share in cash for Walgreens. Shareholders could also receive up to $3 more per share in the future from sales of Walgreens' primary-care businesses, including Village Medical, Summit Health and CityMD.Including debt...
Walgreens allegedly closing in on $10B deal to go private
Walgreens Boots Alliance Inc. is supposedly nearing a deal with private equity firm Sycamore Partners to go private for around $10 billion, the Wall Street Journal reported, citing people familiar with the matter. The two sides are aiming to finish up a deal as soon as Thursday and have been talking about Sycamore paying between $11.30 a share and $11.40 a share in cash, the unnamed sources said. If Sycamore completes the deal for the whole company,...
Purdue Pharma owners to pay up to $7.4B in opioid settlement
New York Attorney General Letitia James announced on Thursday that the Sackler family members, who own the OxyContin maker Purdue Pharma, reached a settlement to pay up to $7.4 billion "for their instrumental role in creating the opioid crisis."According to the new settlement, the Purdue Pharma owners will contribute up to $7.4 billion over the span of 15 years, with a portion of the money going to the victims of the opioid crisis. The first payment of $1.5...
Walgreens falls 12% after DOJ opioid prescription lawsuit
Walgreens Boots Alliance Inc.'s shares tumbled by more than 12% on Tuesday, after the United States Department of Justice filed a lawsuit against the company and its subsidiaries, accusing it of dispensing millions of prescriptions, including those for "dangerous and excessive quantities" of opioids, that "lacked a legitimate medical purpose."According to the lawsuit, if the company is found liable, it will have to pay civil penalties of up to $80,850 for every...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.